Stressgen Biotechnologies Corporation
6055 Lusk Boulevard
San Diego
California
92121
United States
Tel: 858-202-4900
Fax: 858-450-6849
Website: http://www.stressgen.com/
18 articles about Stressgen Biotechnologies Corporation
-
Nventa Biopharmaceuticals Corporation To Receive $2.8 Million From Escrow Account
8/4/2006
-
Nventa Biopharmaceuticals Corporation Granted European Patent Covering Heat Shock Protein Fusion To Treat Influenza
6/7/2006
-
Stressgen Biotechnologies Corporation Changes Name To Nventa Biopharmaceuticals Corporation
6/2/2006
-
Stressgen Biotechnologies Corporation Announces First Quarter 2006 Financial Results
5/12/2006
-
Stressgen Biotechnologies Corporation To Present At Upcoming BioFinance 2006 Conference In Toronto
5/3/2006
-
Stressgen Biotechnologies Corporation Provides Corporate And HspE7 Program Updates
4/20/2006
-
Stressgen Biotechnologies Corporation Announces New Head Of Research & Development
4/18/2006
-
Stressgen Biotechnologies Corporation Announces Changes To Its Board Of Directors
4/6/2006
-
Stressgen Biotechnologies Corporation Release: TSX Issues Bulletin Confirming Substitutional Listing
3/29/2006
-
Stressgen Biotechnologies Corporation Completes Corporate Transaction
3/24/2006
-
Stressgen Biotechnologies Corporation Announces 2005 Financial Results
3/22/2006
-
Stressgen Biotechnologies Corporation Obtains Securityholder Approval For Corporate Transaction
3/17/2006
-
Stressgen Biotechnologies Corporation Updates Shareholders On Special Shareholder Meeting Set For March 16, 2006
3/3/2006
-
Stressgen Biotechnologies Corporation Restructures With $9-Million Loan
1/30/2006
-
Stressgen Biotechnologies Corporation Receives Final Proceeds From Sale Of Bioreagent Business
1/17/2006
-
Stressgen Biotechnologies Corporation Announces Closing Of Overallotment Option
12/14/2005
-
Stressgen Biotechnologies Corporation Announces Third Quarter 2005 Financial Results
11/8/2005
-
Stressgen Biotechnologies Corporation's European Patent Upheld Against Antigenics' Challenge
10/20/2005